Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tecnofer is an oral iron food supplement developed by Laboratori Baldacci, primarily indicated for the treatment and prevention of iron deficiency and iron deficiency anemia. It is formulated with Feralgina (Feralgine), a patented, co-processed compound containing chelated ferrous bisglycinate and sodium alginate in a 1:1 ratio. The chelated structure of ferrous bisglycinate protects the iron from interacting with dietary inhibitors in the gastrointestinal tract, enhancing its bioavailability and absorption. Sodium alginate co-processing further improves the distribution of iron along the gastrointestinal mucosa, accelerating absorption and significantly reducing common gastrointestinal side effects such as nausea, constipation, and abdominal pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tecnofer.